NDC 0173-0892 – Nucala
Mepolizumab 100 mg/mL · Injection, Solution · Subcutaneous
Product NDC0173-0892
Product details
- Brand name
- Nucala
- Generic name
- Mepolizumab
- Labeler
- GlaxoSmithKline LLC
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761122
- Marketed since
- June 6, 2019
- Listing expires
- December 31, 2026
- Pharmacologic class
- Interleukin-5 Antagonist
Active ingredients
- Mepolizumab 100 mg/mL
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 0173-0892-01 | 1 SYRINGE in 1 CARTON (0173-0892-01) / 1 mL in 1 SYRINGE | Jun 6, 2019 |
| 0173-0892-42 | 1 SYRINGE in 1 CARTON (0173-0892-42) / 1 mL in 1 SYRINGE | Jun 6, 2019 |
| 0173-0892-61 | 1 SYRINGE in 1 CARTON (0173-0892-61) / 1 mL in 1 SYRINGE | Jun 6, 2019 |
| 0173-0892-63 | 1 SYRINGE in 1 CARTON (0173-0892-63) / 1 mL in 1 SYRINGE | Jun 6, 2019 |
Recalls mentioning this NDC
- D-1876-2019 Oct 2, 2019 · Class II
Temperature Abuse; Product stored and shipped outside of labeled storage requirements.